514 related articles for article (PubMed ID: 16763014)
1. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.
Sten T; Qvisen S; Uutela P; Luukkanen L; Kostiainen R; Finel M
Drug Metab Dispos; 2006 Sep; 34(9):1488-94. PubMed ID: 16763014
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective glucuronidation of propranolol in human and cynomolgus monkey liver microsomes: role of human hepatic UDP-glucuronosyltransferase isoforms, UGT1A9, UGT2B4 and UGT2B7.
Hanioka N; Hayashi K; Shimizudani T; Nagaoka K; Koeda A; Naito S; Narimatsu S
Pharmacology; 2008; 82(4):293-303. PubMed ID: 18936551
[TBL] [Abstract][Full Text] [Related]
3. How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?
Itäaho K; Laakkonen L; Finel M
Drug Metab Dispos; 2010 Apr; 38(4):687-96. PubMed ID: 20089735
[TBL] [Abstract][Full Text] [Related]
4. The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.
Itäaho K; Mackenzie PI; Ikushiro S; Miners JO; Finel M
Drug Metab Dispos; 2008 Nov; 36(11):2307-15. PubMed ID: 18719240
[TBL] [Abstract][Full Text] [Related]
5. The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7.
Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
Drug Metab Dispos; 2007 Mar; 35(3):363-70. PubMed ID: 17151189
[TBL] [Abstract][Full Text] [Related]
6. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
7. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective metabolism of propranolol glucuronidation by human UDP-glucuronosyltransferases 2B7 and 1A9.
Yu L; Qian M; Liu Y; Yao T; Zeng S
Chirality; 2010 May; 22(4):456-61. PubMed ID: 19644937
[TBL] [Abstract][Full Text] [Related]
9. Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases.
Kuuranne T; Kurkela M; Thevis M; Schänzer W; Finel M; Kostiainen R
Drug Metab Dispos; 2003 Sep; 31(9):1117-24. PubMed ID: 12920167
[TBL] [Abstract][Full Text] [Related]
10. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L
Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190
[TBL] [Abstract][Full Text] [Related]
11. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
[TBL] [Abstract][Full Text] [Related]
12. Stereoselectivity and interaction between the glucuronidation of S-(-)- and R-(+)-propranolol in rat hepatic microsomes pretreated with different inducers.
Luan LJ; Shao Q; Zeng S
Pharmazie; 2005 Mar; 60(3):221-4. PubMed ID: 15801678
[TBL] [Abstract][Full Text] [Related]
13. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
Hanioka N; Naito T; Narimatsu S
Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
[TBL] [Abstract][Full Text] [Related]
14. Glucuronidation of mono(2-ethylhexyl) phthalate in humans: roles of hepatic and intestinal UDP-glucuronosyltransferases.
Hanioka N; Kinashi Y; Tanaka-Kagawa T; Isobe T; Jinno H
Arch Toxicol; 2017 Feb; 91(2):689-698. PubMed ID: 27071666
[TBL] [Abstract][Full Text] [Related]
15. The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan.
Alonen A; Finel M; Kostiainen R
Biochem Pharmacol; 2008 Sep; 76(6):763-72. PubMed ID: 18674515
[TBL] [Abstract][Full Text] [Related]
16. Sulfinpyrazone C-glucuronidation is catalyzed selectively by human UDP-glucuronosyltransferase 1A9.
Kerdpin O; Elliot DJ; Mackenzie PI; Miners JO
Drug Metab Dispos; 2006 Dec; 34(12):1950-3. PubMed ID: 16985098
[TBL] [Abstract][Full Text] [Related]
17. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes.
Yamanaka H; Nakajima M; Katoh M; Kanoh A; Tamura O; Ishibashi H; Yokoi T
Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective glucuronidation of carvedilol in human liver and intestinal microsomes.
Hanioka N; Tanaka S; Moriguchi Y; Narimatsu S
Pharmacology; 2012; 90(3-4):117-24. PubMed ID: 22814440
[TBL] [Abstract][Full Text] [Related]
19. Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10.
Mizuma T
Int J Pharm; 2009 Aug; 378(1-2):140-1. PubMed ID: 19486934
[TBL] [Abstract][Full Text] [Related]
20. Glucuronidation of racemic O-desmethyltramadol, the active metabolite of tramadol.
Lehtonen P; Sten T; Aitio O; Kurkela M; Vuorensola K; Finel M; Kostiainen R
Eur J Pharm Sci; 2010 Nov; 41(3-4):523-30. PubMed ID: 20797434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]